Meda introduces RAID Shuttle Storage

Medéa Corp. debuted its new RAID Shuttle system at the 2004 International Telemetering Conference (ITC) October 19-21, in San Diego. Medéa also showcased its XStream and VideoRAID FCR2X disk arrays.

Medéa's RAID Shuttle is a small, high performance disk storage array that offers 1.6 TeraByte (TB) of storage on removable disk drives. It is contained in a shockproof compact enclosure that protects data in harsh environments, said Medéa.

The system's Fibre Channel interface provides high data transfer rates of up to 200 MB/second, and sustained data transfer rates of 180 MB/second. Using standard CPU software, the Medéa RAID Shuttle is compatible with all standard Fibre Channel/SCSI software and is also interoperable with all major host adapters from leading manufacturers like QLogic, ATTO and Emulex.

The Medéa XStream is a scalable storage system designed for near-line applications. Users can start with a 1TB system and then scale to over 4TB in a single 3U rack by adding additional disk drive modules, said Medéa. XStream disk arrays can also be daisy-chained or SAN attached for installations requiring storage in the hundreds of TBs. The Medéa XStream provides a data transfer rate of over 170 MB/second.

The Medéa VideoRaid FCR2X disk array features single or dual-channel 2-Gbit Fibre Channel interface. The VideoRaid FCR2X is available in 5- and 10-drive, 3U rack mountable configurations with capacities up to 3.2TB. FCR2X is compatible with both MAC and Windows-based platforms.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.